EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.

Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: The delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial

P. Ruggenenti
G. Lauria
I.P. Iliev
A. Fassi
A.P. Ilieva
S. Rota
C. Chiurchiu
D.P. Barlovic
A. Sghirlanzoni
R. Lombardi
P. Penza
G. Cavaletti
M.L. Piatti
B. Frigeni
M. Filipponi
N. Rubis
G. Noris
N. Motterlini
B. Ene-Iordache
F. Gaspari
A. Perna
J. Zaletel
A. Bossi
A.R. Dodesini
R. Trevisan
G. Remuzzi

November 2011

To assess whether angiotensin-converting enzyme inhibitors and third-generation dihydropyridine calc...

Once-daily prandial lixisenatide versus once-daily rapid-acting insulin in patients with type 2 diabetes mellitus insufficiently controlled with basal insulin: analysis of data from five randomized, controlled trials

Raccah D
Lin J
Wang E
Germé M
Perfetti R
de Pablos Velasco P
Roussel R
Rosenstock J.
BONADONNA, Riccardo

January 2014

AIMS: To compare the efficacy and safety of lixisenatide (LIXI), a once-daily prandial glucagon-lik...

Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial

Tonneijck, Lennart
Muskiet, Marcel H.A.
Smits, Mark M.
Hoekstra, Trynke
Kramer, Mark H.H.
Danser, A. H.Jan
Diamant, Michaela
Joles, Jaap A.
van Raalte, Daniël H.

December 2017

Aim: To determine whether lixisenatide, a prandial short-acting glucagon-like peptide receptor agoni...

EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.

Mogensen Ce
Neldam S
Tikkanen I Et Al
Teo Kk
Pogue J
Dyal L Et Al. Telmisartan
Bakris Gl
Ruilope L
Locatelli F Et Al
Julia Platts

October 2015

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertensi...

Clinical study of the month. The CALM study assessing the combination of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist in the treatment of diabetic nephropathy

Philips, Jean-Christophe
Weekers, Laurent
Scheen, André

January 2001

peer reviewedThe main objective of the CALM (Candesartan And Lisinopril Microalbuminuria) study is t...

Long-term dual blockade with candesartan and lisinopril in hypertensive patients with diabetes: the CALM II study. Diabetes Care

Niels H. Andersen
Per L Poulsen
Søren T. Knudsen
Steen H. Poulsen
Hans Eiskjær
Klavs W. Hansen
Kjeld Helleberg Md
Carl E. Mogensen

October 2016

OBJECTIVE — To assess and compare the long-term effects of the combination of candesar-tan and lisin...

6. Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and

Mogensen Ce
Neldam S
Tikkanen I Et Al. R
Omised Controlled
Oparil S
Yarows Sa
Patel S Et Al. Efficacy

September 2016

trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, ...

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

Mogensen, C. E.
Neldam, S.
Tikkanen, I.
Oren, S.
Viskoper, R.
Watts, Richard Walter
Cooper, Mark E.

January 2000

Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria

Chaturvedi N
Stevenson J
Fuller JH
Rottiers R
Ferriss B
Karamanos B
Kofinis A
Petrou C
IonescuTirgovisite C
Iosif C
Tamas G
Bibok G
Kerenyi Z
KisGombos P
Toth J
Grealy G
Priem H
Koivisto V
Tuominen J
Kostamo E
IdziorWalus B
Solnica B
GalickaLatalie D
Michel G
Keipes M
Giuliani A
Herode A
Santeusanio F
Bueti A
Bistoni S
Cagini
Navalesi R
Penno G
Nannipieri M
Rizzo L
Miccoli R
Ghirlanda G
Cotroneo P
Manto A
Minella A
Saponara C
Ward J
Plater M
Ibrahim S
Ibbotson S
Mody C
Papazoglou N
Manes C
Soulis K
Voukias M
Muggeo M
Cacciatori V
Gemma ML
Dellera A
Castellarin A
Irsigler K
Abrahamian H
Gurdet C
Willinger C
Nelstrop A
Feben C
Walford S
McLelland V
Hughes S
Metelko Z
Roglic G
Pepeonik ZR
Stephenson J
Viberti GC
Sjolie AK
Holloway J
Milne M
Webb D
Bulpitt C
Fletcher A
Shipley M
John G
Newman DJ

January 1997

Background Renal disease in people with insulin-dependent diabetes (IDDM) continues to pose a major ...

LISINOPRIL USAGE IN CARDIOLOGIC PRACTICE: DATA OF EVIDENCE BASED MEDICINE

N. P. Kutishenko
S. J. Martsevich

December 2015

<p>Data of multicenter clinical trials on assessment of angiotensin converting enzyme inhibitor, lis...

Placebo-controlled study of lisinopril in congestive heart failure: A multicentre study

Chalmers, John J.P.
Schuster, Peter
Sialer, S.
Simon, H.
Stephenson, John
Watson, R.D.S.
West, Malcolm M.J.
Cyran, Joachim
De La Torre, D.
Englert, Marc
Kramar, M.
Lewis, Gerald R J
Maranhao, Mara Fernandes L
Myburgh, Dirk Petrus

January 1987

A double-blind randomised, parallel, placebo-controlled study was performed in patients with congest...

The effect of Lisinopril on blood glucose level given alone and in combination with oral anti-diabetic drugs in alloxan-induced diabetic rats

Agrawal, Neeraj K.
Gupta, Uma

July 2013

Background: In diabetic patients, ACE (Angiotensin converting enzyme) inhibitors prevent the develop...

Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients

Thurig, Ch
Bohlen, Lorenz
Schneider, M
de Courten, Maximilian
Shaw, S. G
Riesen, W
Weidmann, Peter

January 1995

To investigate the effects of antihypertensive treatment with the angiotensin-converting enzyme (ACE...

Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients

FOGARI, ROBERTO
MUGELLINI, AMEDEO
Zoppi A
Corradi L
Lazzari P
Lusardi P.

January 1998

AIMS: The aim of this study was to compare the effects of the ACE-inhibitor lisinopril and the angio...

Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine

Agardh, Carl-David
Garcia-Puig, J
Charbonnel, B
Angelkort, B
Barnett, A H

January 1996

A double-blind, randomised, parallel group, multicentre, multinational study compared the effects of...

Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: The delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial

P. Ruggenenti
G. Lauria
I.P. Iliev
A. Fassi
A.P. Ilieva
S. Rota
C. Chiurchiu
D.P. Barlovic
A. Sghirlanzoni
R. Lombardi
P. Penza
G. Cavaletti
M.L. Piatti
B. Frigeni
M. Filipponi
N. Rubis
G. Noris
N. Motterlini
B. Ene-Iordache
F. Gaspari
A. Perna
J. Zaletel
A. Bossi
A.R. Dodesini
R. Trevisan
G. Remuzzi

November 2011

To assess whether angiotensin-converting enzyme inhibitors and third-generation dihydropyridine calc...

Once-daily prandial lixisenatide versus once-daily rapid-acting insulin in patients with type 2 diabetes mellitus insufficiently controlled with basal insulin: analysis of data from five randomized, controlled trials

Raccah D
Lin J
Wang E
Germé M
Perfetti R
de Pablos Velasco P
Roussel R
Rosenstock J.
BONADONNA, Riccardo

January 2014

AIMS: To compare the efficacy and safety of lixisenatide (LIXI), a once-daily prandial glucagon-lik...

Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial

Tonneijck, Lennart
Muskiet, Marcel H.A.
Smits, Mark M.
Hoekstra, Trynke
Kramer, Mark H.H.
Danser, A. H.Jan
Diamant, Michaela
Joles, Jaap A.
van Raalte, Daniël H.

December 2017

Aim: To determine whether lixisenatide, a prandial short-acting glucagon-like peptide receptor agoni...

EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.

Mogensen Ce
Neldam S
Tikkanen I Et Al
Teo Kk
Pogue J
Dyal L Et Al. Telmisartan
Bakris Gl
Ruilope L
Locatelli F Et Al
Julia Platts

October 2015

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertensi...

Clinical study of the month. The CALM study assessing the combination of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist in the treatment of diabetic nephropathy

Philips, Jean-Christophe
Weekers, Laurent
Scheen, André

January 2001

peer reviewedThe main objective of the CALM (Candesartan And Lisinopril Microalbuminuria) study is t...

Long-term dual blockade with candesartan and lisinopril in hypertensive patients with diabetes: the CALM II study. Diabetes Care

Niels H. Andersen
Per L Poulsen
Søren T. Knudsen
Steen H. Poulsen
Hans Eiskjær
Klavs W. Hansen
Kjeld Helleberg Md
Carl E. Mogensen

October 2016

OBJECTIVE — To assess and compare the long-term effects of the combination of candesar-tan and lisin...

6. Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and

Mogensen Ce
Neldam S
Tikkanen I Et Al. R
Omised Controlled
Oparil S
Yarows Sa
Patel S Et Al. Efficacy

September 2016

trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, ...

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

Mogensen, C. E.
Neldam, S.
Tikkanen, I.
Oren, S.
Viskoper, R.
Watts, Richard Walter
Cooper, Mark E.

January 2000

Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria

Chaturvedi N
Stevenson J
Fuller JH
Rottiers R
Ferriss B
Karamanos B
Kofinis A
Petrou C
IonescuTirgovisite C
Iosif C
Tamas G
Bibok G
Kerenyi Z
KisGombos P
Toth J
Grealy G
Priem H
Koivisto V
Tuominen J
Kostamo E
IdziorWalus B
Solnica B
GalickaLatalie D
Michel G
Keipes M
Giuliani A
Herode A
Santeusanio F
Bueti A
Bistoni S
Cagini
Navalesi R
Penno G
Nannipieri M
Rizzo L
Miccoli R
Ghirlanda G
Cotroneo P
Manto A
Minella A
Saponara C
Ward J
Plater M
Ibrahim S
Ibbotson S
Mody C
Papazoglou N
Manes C
Soulis K
Voukias M
Muggeo M
Cacciatori V
Gemma ML
Dellera A
Castellarin A
Irsigler K
Abrahamian H
Gurdet C
Willinger C
Nelstrop A
Feben C
Walford S
McLelland V
Hughes S
Metelko Z
Roglic G
Pepeonik ZR
Stephenson J
Viberti GC
Sjolie AK
Holloway J
Milne M
Webb D
Bulpitt C
Fletcher A
Shipley M
John G
Newman DJ

January 1997

Background Renal disease in people with insulin-dependent diabetes (IDDM) continues to pose a major ...

LISINOPRIL USAGE IN CARDIOLOGIC PRACTICE: DATA OF EVIDENCE BASED MEDICINE

N. P. Kutishenko
S. J. Martsevich

December 2015

<p>Data of multicenter clinical trials on assessment of angiotensin converting enzyme inhibitor, lis...

Placebo-controlled study of lisinopril in congestive heart failure: A multicentre study

Chalmers, John J.P.
Schuster, Peter
Sialer, S.
Simon, H.
Stephenson, John
Watson, R.D.S.
West, Malcolm M.J.
Cyran, Joachim
De La Torre, D.
Englert, Marc
Kramar, M.
Lewis, Gerald R J
Maranhao, Mara Fernandes L
Myburgh, Dirk Petrus

January 1987

A double-blind randomised, parallel, placebo-controlled study was performed in patients with congest...

The effect of Lisinopril on blood glucose level given alone and in combination with oral anti-diabetic drugs in alloxan-induced diabetic rats

Agrawal, Neeraj K.
Gupta, Uma

July 2013

Background: In diabetic patients, ACE (Angiotensin converting enzyme) inhibitors prevent the develop...

Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients

Thurig, Ch
Bohlen, Lorenz
Schneider, M
de Courten, Maximilian
Shaw, S. G
Riesen, W
Weidmann, Peter

January 1995

To investigate the effects of antihypertensive treatment with the angiotensin-converting enzyme (ACE...

Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients

FOGARI, ROBERTO
MUGELLINI, AMEDEO
Zoppi A
Corradi L
Lazzari P
Lusardi P.

January 1998

AIMS: The aim of this study was to compare the effects of the ACE-inhibitor lisinopril and the angio...

Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine

Agardh, Carl-David
Garcia-Puig, J
Charbonnel, B
Angelkort, B
Barnett, A H

January 1996

A double-blind, randomised, parallel group, multicentre, multinational study compared the effects of...

Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: The delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial

P. Ruggenenti
G. Lauria
I.P. Iliev
A. Fassi
A.P. Ilieva
S. Rota
C. Chiurchiu
D.P. Barlovic
A. Sghirlanzoni
R. Lombardi
P. Penza
G. Cavaletti
M.L. Piatti
B. Frigeni
M. Filipponi
N. Rubis
G. Noris
N. Motterlini
B. Ene-Iordache
F. Gaspari
A. Perna
J. Zaletel
A. Bossi
A.R. Dodesini
R. Trevisan
G. Remuzzi

November 2011

To assess whether angiotensin-converting enzyme inhibitors and third-generation dihydropyridine calc...

Once-daily prandial lixisenatide versus once-daily rapid-acting insulin in patients with type 2 diabetes mellitus insufficiently controlled with basal insulin: analysis of data from five randomized, controlled trials

Raccah D
Lin J
Wang E
Germé M
Perfetti R
de Pablos Velasco P
Roussel R
Rosenstock J.
BONADONNA, Riccardo

January 2014

AIMS: To compare the efficacy and safety of lixisenatide (LIXI), a once-daily prandial glucagon-lik...

Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial

Tonneijck, Lennart
Muskiet, Marcel H.A.
Smits, Mark M.
Hoekstra, Trynke
Kramer, Mark H.H.
Danser, A. H.Jan
Diamant, Michaela
Joles, Jaap A.
van Raalte, Daniël H.

December 2017

Aim: To determine whether lixisenatide, a prandial short-acting glucagon-like peptide receptor agoni...

EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.

Abstract

Extracted data

EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.

Abstract

Extracted data

Related items

Related items